These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22958446)

  • 1. Real-time assessment of cigarette smoke particle deposition in vitro.
    Adamson J; Hughes S; Azzopardi D; McAughey J; Gaça MD
    Chem Cent J; 2012 Sep; 6(1):98. PubMed ID: 22958446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of an in vitro whole cigarette smoke exposure system: The Borgwaldt RM20S 8-syringe smoking machine.
    Adamson J; Azzopardi D; Errington G; Dickens C; McAughey J; Gaça MD
    Chem Cent J; 2011 Aug; 5():50. PubMed ID: 21867559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantification of cigarette smoke particle deposition in vitro using a triplicate quartz crystal microbalance exposure chamber.
    Adamson J; Thorne D; McAughey J; Dillon D; Meredith C
    Biomed Res Int; 2013; 2013():685074. PubMed ID: 23484139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of precision and accuracy of the Borgwaldt RM20S(®) smoking machine designed for in vitro exposure.
    Kaur N; Lacasse M; Roy JP; Cabral JL; Adamson J; Errington G; Waldron KC; Gaça M; Morin A
    Inhal Toxicol; 2010 Dec; 22(14):1174-83. PubMed ID: 21126153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of cigarette smoke particle deposition within the Vitrocell® exposure module using quartz crystal microbalances.
    Adamson J; Thorne D; Dalrymple A; Dillon D; Meredith C
    Chem Cent J; 2013; 7():50. PubMed ID: 23497606
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The comparative in vitro assessment of e-cigarette and cigarette smoke aerosols using the γH2AX assay and applied dose measurements.
    Thorne D; Larard S; Baxter A; Meredith C; Gaҫa M
    Toxicol Lett; 2017 Jan; 265():170-178. PubMed ID: 27965004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of in vitro cigarette smoke exposure systems.
    Thorne D; Adamson J
    Exp Toxicol Pathol; 2013 Nov; 65(7-8):1183-93. PubMed ID: 23850067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Headspace stir bar sorptive extraction-gas chromatography/mass spectrometry characterization of the diluted vapor phase of cigarette smoke delivered to an in vitro cell exposure chamber.
    Kaur N; Cabral JL; Morin A; Waldron KC
    J Chromatogr A; 2011 Jan; 1218(2):324-33. PubMed ID: 21163485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterisation of an aerosol exposure system to evaluate the genotoxicity of whole mainstream cigarette smoke using the in vitro γH2AX assay by high content screening.
    Garcia-Canton C; Errington G; Anadon A; Meredith C
    BMC Pharmacol Toxicol; 2014 Jul; 15():41. PubMed ID: 25056295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determining real-time mass deposition with a quartz crystal microbalance in an electrostatic, parallel-flow, air-liquid interface exposure system.
    Kaur K; Overacker D; Ghandehari H; Reilly C; Paine R; Kelly KE
    J Aerosol Sci; 2021 Jan; 151():. PubMed ID: 33012843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mutagenic assessment of mainstream cigarette smoke using the Ames assay: a multi-strain approach.
    Thorne D; Kilford J; Hollings M; Dalrymple A; Ballantyne M; Meredith C; Dillon D
    Mutat Res Genet Toxicol Environ Mutagen; 2015 Apr; 782():9-17. PubMed ID: 25868126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The mutagenic assessment of an electronic-cigarette and reference cigarette smoke using the Ames assay in strains TA98 and TA100.
    Thorne D; Crooks I; Hollings M; Seymour A; Meredith C; Gaca M
    Mutat Res Genet Toxicol Environ Mutagen; 2016 Dec; 812():29-38. PubMed ID: 27908385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A method for assessment of the genotoxicity of mainstream cigarette-smoke by use of the bacterial reverse-mutation assay and an aerosol-based exposure system.
    Kilford J; Thorne D; Payne R; Dalrymple A; Clements J; Meredith C; Dillon D
    Mutat Res Genet Toxicol Environ Mutagen; 2014 Jul; 769():20-8. PubMed ID: 25344108
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative assessment of e-cigarette aerosols and cigarette smoke on in vitro endothelial cell migration.
    Taylor M; Jaunky T; Hewitt K; Breheny D; Lowe F; Fearon IM; Gaca M
    Toxicol Lett; 2017 Aug; 277():123-128. PubMed ID: 28658606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In Vitro Systems Toxicology Assessment of a Candidate Modified Risk Tobacco Product Shows Reduced Toxicity Compared to That of a Conventional Cigarette.
    Gonzalez-Suarez I; Martin F; Marescotti D; Guedj E; Acali S; Johne S; Dulize R; Baumer K; Peric D; Goedertier D; Frentzel S; Ivanov NV; Mathis C; Hoeng J; Peitsch MC
    Chem Res Toxicol; 2016 Jan; 29(1):3-18. PubMed ID: 26651182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a quantitative method for assessment of dose in in vitro evaluations using a VITROCELL® VC10® smoke exposure system.
    Keyser BM; Leverette R; Fowler K; Fields W; Hargreaves V; Reeve L; Bombick B
    Toxicol In Vitro; 2019 Apr; 56():19-29. PubMed ID: 30576853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A consideration of the role of gas/particle partitioning in the deposition of nicotine and other tobacco smoke compounds in the respiratory tract.
    Pankow JF
    Chem Res Toxicol; 2001 Nov; 14(11):1465-81. PubMed ID: 11712903
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemical analysis of cigarette smoke particulate generated in the MSB-01 in vitro whole smoke exposure system.
    Scian MJ; Oldham MJ; Miller JH; Kane DB; Edmiston JS; McKinney WJ
    Inhal Toxicol; 2009 Oct; 21(12):1040-52. PubMed ID: 19772483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Particulate matter emissions of four types of one cigarette brand with and without additives: a laser spectrometric particulate matter analysis of secondhand smoke.
    Braun M; Fromm EL; Gerber A; Klingelhöfer D; Müller R; Groneberg DA
    BMJ Open; 2019 Jan; 9(1):e024400. PubMed ID: 30782733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mainstream Smoke Levels of Volatile Organic Compounds in 50 U.S. Domestic Cigarette Brands Smoked With the ISO and Canadian Intense Protocols.
    Pazo DY; Moliere F; Sampson MM; Reese CM; Agnew-Heard KA; Walters MJ; Holman MR; Blount BC; Watson CH; Chambers DM
    Nicotine Tob Res; 2016 Sep; 18(9):1886-94. PubMed ID: 27113015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.